NCT00274105View on ClinicalTrials.gov

SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 1, 2001

Primary Completion Date

October 1, 2004

Study Completion Date

October 1, 2004

Conditions
HypertensionCoronary Arteriosclerosis
Interventions
DRUG

telmisartan

DRUG

Placebo

Trial Locations (2)

10117

Universitätsklinikum Charité, Berlin

30623

Med. Hochschule Hannover, Hanover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY